Search alternatives:
linear decrease » linear increase (Expand Search)
higher decrease » higher degree (Expand Search), higher degrees (Expand Search), highest increase (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 4,041 - 4,060 results of 18,621 for search '(( significantly ((a decrease) OR (linear decrease)) ) OR ( significantly higher decrease ))', query time: 0.69s Refine Results
  1. 4041
    Illustrates photographs of the CAM were captured to visualize the vascular plexus following the control group, native-orientin (5 μM), native-orientin (10 μM), NF-O (5 μM), and NF-O (10 μM).

    Illustrates photographs of the CAM were captured to visualize the vascular plexus following the control group, native-orientin (5 μM), native-orientin (10 μM), NF-O (5 μM), and NF-... by Yashwanth Elumalai (21743452)

    Published 2025
    Save to List
    Saved in:
  2. 4042
    Stereotactic injection of AAV-miR-129-5p attenuated microglia activation in depressed mice.

    Stereotactic injection of AAV-miR-129-5p attenuated microglia activation in depressed mice. by Qiaozhen Qin (13159201)

    Published 2025
    Save to List
    Saved in:
  3. 4043
    Stereotactic injection of AAV-miR-129-5p suppressed astrocyte activation in depressed mice.

    Stereotactic injection of AAV-miR-129-5p suppressed astrocyte activation in depressed mice. by Qiaozhen Qin (13159201)

    Published 2025
    Save to List
    Saved in:
  4. 4044
    Overexpression of miR-129-5p alleviated depression-like behaviors by increasing ATP content.

    Overexpression of miR-129-5p alleviated depression-like behaviors by increasing ATP content. by Qiaozhen Qin (13159201)

    Published 2025
    Save to List
    Saved in:
  5. 4045
    Overexpression of miR-129-5p alleviated the depressive-like phenotypes of CRS and LPS treated mice.

    Overexpression of miR-129-5p alleviated the depressive-like phenotypes of CRS and LPS treated mice. by Qiaozhen Qin (13159201)

    Published 2025
    Save to List
    Saved in:
  6. 4046
    Participant demographic and clinical characteristics.

    Participant demographic and clinical characteristics. by Claire M. Douglas (21238238)

    Published 2025
    Save to List
    Saved in:
  7. 4047
    Quality of life scores at baseline (week 0) and end of chemotherapy (week 18) in the DHA and placebo groups.

    Quality of life scores at baseline (week 0) and end of chemotherapy (week 18) in the DHA and placebo groups. by Claire M. Douglas (21238238)

    Published 2025
    Save to List
    Saved in:
  8. 4048
    Effects of FSAE in rabbits (n

    Effects of FSAE in rabbits (n by Houkang Ding (20968091)

    Published 2025
    Save to List
    Saved in:
  9. 4049
    Interaction profile of targeted receptor molecules and orientin.

    Interaction profile of targeted receptor molecules and orientin. by Yashwanth Elumalai (21743452)

    Published 2025
    Save to List
    Saved in:
  10. 4050
    OPLS-DA score plot and volcano plot in the control and diarrhea groups.

    OPLS-DA score plot and volcano plot in the control and diarrhea groups. by Houkang Ding (20968091)

    Published 2025
    Save to List
    Saved in:
  11. 4051
    Diverse regulatory gate forms.

    Diverse regulatory gate forms. by Jeong-Soo Gim (18058588)

    Published 2025
    Save to List
    Saved in:
  12. 4052
    Fourier Transform Infra-Red Spectroscopy (FT-IR) of Native Orientin and NF-Orientin.

    Fourier Transform Infra-Red Spectroscopy (FT-IR) of Native Orientin and NF-Orientin. by Yashwanth Elumalai (21743452)

    Published 2025
    Save to List
    Saved in:
  13. 4053
    Synthesis preparation of nano-formulated orientin by using solvent evaporation method.

    Synthesis preparation of nano-formulated orientin by using solvent evaporation method. by Yashwanth Elumalai (21743452)

    Published 2025
    Save to List
    Saved in:
  14. 4054
    UV-Spectrophotometer of Native Orientin and NF-Orientin.

    UV-Spectrophotometer of Native Orientin and NF-Orientin. by Yashwanth Elumalai (21743452)

    Published 2025
    Save to List
    Saved in:
  15. 4055
    Illustrates the schematic representation of <i>in ova</i> experimentation showing with timeline.

    Illustrates the schematic representation of <i>in ova</i> experimentation showing with timeline. by Yashwanth Elumalai (21743452)

    Published 2025
    Save to List
    Saved in:
  16. 4056
    The results of self-organising map (SOM) clustering.

    The results of self-organising map (SOM) clustering. by Jeong-Soo Gim (18058588)

    Published 2025
    Save to List
    Saved in:
  17. 4057
    Microscopic pictorial representation of wound healing assay (Control, native orientin (NF) and NF-O in 0 h and 24 h).

    Microscopic pictorial representation of wound healing assay (Control, native orientin (NF) and NF-O in 0 h and 24 h). by Yashwanth Elumalai (21743452)

    Published 2025
    Save to List
    Saved in:
  18. 4058
    Flow of participants through the DHA WIN RCT. Abbreviations: Docosahexaenoic acid (DHA), Docosahexaenoic acid for Women with Breast Cancer in the Neoadjuvant Setting (DHA WIN), randomized controlled trial (RCT).

    Flow of participants through the DHA WIN RCT. Abbreviations: Docosahexaenoic acid (DHA), Docosahexaenoic acid for Women with Breast Cancer in the Neoadjuvant Setting (DHA WIN), ran... by Claire M. Douglas (21238238)

    Published 2025
    Save to List
    Saved in:
  19. 4059
    Description of the study sites in the NRE.

    Description of the study sites in the NRE. by Jeong-Soo Gim (18058588)

    Published 2025
    Save to List
    Saved in:
  20. 4060
    Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 150 minutes/week) or did not meet (< 150 minutes/week) WHO’s aerobic exercise recommendation on average during chemotherapy.

    Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 150 minutes/week) or did not meet (< 150 minutes/week) WHO’s aerobic e... by Claire M. Douglas (21238238)

    Published 2025
    Save to List
    Saved in:

Search Tools: